HALEY, George T.; HALEY, Usha C.V. The effects of patent-law changes on innovation: The case of India's pharmaceutical industry. S. 607–619. Technological Forecasting and Social Change [online]. 2012-05. Roč. 79, čís. 4, s. 607–619. Dostupné online. DOI10.1016/j.techfore.2011.05.012. (anglicky)
BOEHM, Garth; YAO, Lixin; HAN, Liang; ZHENG, Qiang. Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984. S. 297–311. Acta Pharmaceutica Sinica B [online]. 2013-09. Roč. 3, čís. 5, s. 297–311. Dostupné online. DOI10.1016/j.apsb.2013.07.004. (anglicky)
pinsentmasons.com
Mylan boss calls for supplementary protection certificates manufacturing waiver. pinsentmasons.com [online]. [cit. 2021-10-22]. Dostupné online. (anglicky)
reuters.com
DASGUPTA, Neha; MIGLANI, Sanjeev. Exclusive: With U.S. trade under a cloud, China opens to Indian pharma. Reuters [online]. 2018-07-12 [cit. 2021-10-22]. Dostupné online. (anglicky)
sciencedirect.com
HALEY, George T.; HALEY, Usha C.V. The effects of patent-law changes on innovation: The case of India's pharmaceutical industry. S. 607–619. Technological Forecasting and Social Change [online]. 2012-05. Roč. 79, čís. 4, s. 607–619. Dostupné online. DOI10.1016/j.techfore.2011.05.012. (anglicky)
BOEHM, Garth; YAO, Lixin; HAN, Liang; ZHENG, Qiang. Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984. S. 297–311. Acta Pharmaceutica Sinica B [online]. 2013-09. Roč. 3, čís. 5, s. 297–311. Dostupné online. DOI10.1016/j.apsb.2013.07.004. (anglicky)